您的位置: 首页 > 2015年3月 第46卷 第2期 > 文字全文
2023年7月 第38卷 第7期11
目录

穿心莲内酯磺化物雾化吸入对小儿支气管肺炎的疗效和安全性分析

Curative effect and security analyzing for nebulizer inhalation of andrographolide sulfonate to children's bronchopneumonia

来源期刊: 广州医药 | 59-61 发布时间:2021-11-30 收稿时间:2025/11/13 16:49:23 阅读量:25
作者:
关键词:
穿心莲内酯磺化物喜炎平注射液小儿支气管肺炎雾化吸入
Andrographolide sulfonateXiyanpin injectionChildren's bronchopneumoniaNebulizer inhalation
DOI:
10.3969/j.issn.1000-8535.2015.02.021
收稿时间:
2014-12-15 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 研究探讨小儿支气管肺炎应用穿心莲内酯磺化物雾化吸入治疗的临床疗效及安全性。方法 选取2012年7月—2014年6月我院收治并确诊的128例小儿支气管肺炎患儿为研究对象,将所有患儿随机分为对照组和观察组各64例。两组患儿均给予常规退热,消炎、镇咳、平喘、抗病毒感染等治疗,对照组患儿在常规治疗基础上采用红霉素、青霉素和头孢等药物治疗,观察组患儿在常规治疗基础上采用喜炎平注射液雾化吸入治疗,观察两组患儿治疗后退烧时间、肺部啰音消失时间、咳嗽消失时间、临床总有效率以及住院天数。结果 治疗后观察组患儿的各症状消失时间以及住院天数均短于对照组患儿,差异有统计学意义(P<0.05)。观察组患儿总有效率为96.88%高于对照组的85.94%,两组差异有统计学意义(P<0.05)。结论 采用喜炎平注射液雾化吸入治疗小儿支气管肺炎有效果,能效缓解患儿的临床症状,值得大力推广。
Objective To Study and investigate the curative effect and security using nebulizer inhalation of Andrographolide Sulfonate to children's bronchopneumonia. Methods From July,2012 to June, 2014, we chose 128 children who had been diagnosed as bronchopneumonia by our hospital as our research subjects, and divided them into the contrast group and the observation group randomly with 64 children each. The both groups were all treated by using the methods of Antipyretic,anti-inflammatory,antitussive,antiasthmatic,anti-viral infection, treated by using erythromycin, penicillin and cefotaxime in the contrast group,treated the observation group by using Xiyanpin injection by nebulizer inhalation, of cause these two treatment were all on the basis of the conventional treatment. After treatment, we recorded the exact time of when the fever was gone, the disappearing time of pulmonary rales and their cough, the total effective rate and the time of being in hospital of the two groups. Results The time of all the observation group's symptom disappearing and being in hospital was obviously shorter than that of the contrast group after treatment. The difference between both groups was statistically significant(P<0.05). The total effective rate for the observation group was 96.88%, and it's higher than the contrast groups',which was 85.94%. The difference was statistically significant(P<0.05)too. Conclusion Using Xiyanpin injection by nebulizer inhalation for children's bronchopneumonia could effectively relieve the children's clinical symptom. It is worth popularizing for its good clinic medical value.
1、 郭世胜. 痰热清注射液治疗慢性阻塞性肺病急性发作合并肺部感染临床观察[J].亚太传统医药,2014,10(20):112-113. 郭世胜. 痰热清注射液治疗慢性阻塞性肺病急性发作合并肺部感染临床观察[J].亚太传统医药,2014,10(20):112-113.
2、 马红梅,邢彦平,徐锋.痰热清注射液治疗慢性阻塞性肺疾病急性加重期的临床观察[J].吉林大学学报:医学版,2013,9(7):29-30. 马红梅,邢彦平,徐锋.痰热清注射液治疗慢性阻塞性肺疾病急性加重期的临床观察[J].吉林大学学报:医学版,2013,9(7):29-30.
3、 周虹,文富强. 对慢性阻塞性肺疾病中感染问题认识的新进展[J]. 实用医院临床杂志,2009,6(5):9-12. 周虹,文富强. 对慢性阻塞性肺疾病中感染问题认识的新进展[J]. 实用医院临床杂志,2009,6(5):9-12.
4、 刘晓琴,杨雪,胡翠林. 慢性阻塞性肺病伴肺部感染营养不良的危险因素分析[J].实用医院临床杂志,2012,9(5):53-55. 刘晓琴,杨雪,胡翠林. 慢性阻塞性肺病伴肺部感染营养不良的危险因素分析[J].实用医院临床杂志,2012,9(5):53-55.
5、 尤琦红,赵宝英. AECOPD 机械通气患者合并多重耐药菌感染的临床护理[J]. 临床肺科杂志,2011,16(2):327-330. 尤琦红,赵宝英. AECOPD 机械通气患者合并多重耐药菌感染的临床护理[J]. 临床肺科杂志,2011,16(2):327-330.
6、 李艳. 慢性阻塞性肺病肺部感染 36 例临床分析[J].航空航天医学杂志,2011,22(7):801-802. 李艳. 慢性阻塞性肺病肺部感染 36 例临床分析[J].航空航天医学杂志,2011,22(7):801-802.
7、 伦志勇. 慢性阻塞性肺疾病合并肺部真菌感染的临床研究[J].临床医学工程,2010,17(3): 74-76. 伦志勇. 慢性阻塞性肺疾病合并肺部真菌感染的临床研究[J].临床医学工程,2010,17(3): 74-76.
8、 王顺. 慢性阻塞性肺疾病患者继发铜绿假单胞菌肺炎的耐药性调查[J]. 中华医院感染学杂志,2011,21(21): 4592-4593. 王顺. 慢性阻塞性肺疾病患者继发铜绿假单胞菌肺炎的耐药性调查[J]. 中华医院感染学杂志,2011,21(21): 4592-4593.
9、 刘海玲. 慢性阻塞性肺病继发肺部感染不同药物疗效比较[J].临床医学,2013,33(9):64-66. 刘海玲. 慢性阻塞性肺病继发肺部感染不同药物疗效比较[J].临床医学,2013,33(9):64-66.
10、 李华. 慢性阻塞性肺病继发肺部真菌感染20例临床分析[J].中外医疗,2010,1(22):110-111. 李华. 慢性阻塞性肺病继发肺部真菌感染20例临床分析[J].中外医疗,2010,1(22):110-111.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录